Valuation & Earnings
This table compares AppYea and its rivals top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
AppYea | N/A | -$1.82 million | -1.42 |
AppYea Competitors | $17.74 billion | $162.06 million | 60.67 |
AppYea’s rivals have higher revenue and earnings than AppYea. AppYea is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares AppYea and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
AppYea | N/A | N/A | -269.35% |
AppYea Competitors | -636.42% | -109.00% | -16.41% |
Insider and Institutional Ownership
Volatility and Risk
AppYea has a beta of 2.27, meaning that its share price is 127% more volatile than the S&P 500. Comparatively, AppYea’s rivals have a beta of 2.70, meaning that their average share price is 170% more volatile than the S&P 500.
Summary
AppYea rivals beat AppYea on 7 of the 9 factors compared.
AppYea Company Profile
AppYea, Inc., a digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring. It develops AppySleep app, a wristband that monitors physiological parameters during sleep; AppySleep, a biofeedback snoring treatment wristband; AppySleep LAB, a smartphone medical application that monitors breathing patterns in the sleep and identify sleep arena episode without direct contact to the user; and AppySleep PRO a wristband for the treatment of sleep arena using biofeedback in combination with AppySleep LAB app. The company was founded in 2012 and is based in Gan Yavne, Israel.
Receive News & Ratings for AppYea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AppYea and related companies with MarketBeat.com's FREE daily email newsletter.